CCX-140 Uses, Dosage, Side Effects and more
CCX-140 is under investigation in clinical trial NCT01440257 (A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and Albuminuria).
| Trade Name | CCX-140 |
| Generic | CCX-140 |
| Type | |
| Formula | C20H13ClF3N5O3S |
| Weight | Average: 495.86 Monoisotopic: 495.0379727 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
